Saul Levin






















M.D., M.P.A. Chief Executive Officer and Medical Director American Psychiatric Association Dr. Saul Levin is currently the Chief Executive Officer and Medical Director of the American Psychiatric Association. Prior to assuming his role as Chief Executive Officer and Medical Director of the American Psychiatric Association in October 2013, Dr. Saul Levin served as the Interim Director of the District of Columbia Department of Health (DOH). During his tenure, Dr. Levin was responsible for emergency preparedness and planning and coordinating with dozens of federal and local agencies to ensure the public’s health during major events such as President Obama’s second inauguration. Additionally, Dr. Levin promoted the development of a citywide health information exchange that connects health care providers, share critical information to promote patient care, track outcomes, prepare for disasters, and provide for public health surveillance. Dr. Levin also served on the DC Health Exchange Board and chaired the Essential Health Benefits Package Subcommittee where he successfully led the effort to ensure that District residents had access to a full range of substance abuse and mental health services. Finally, Dr. Levin co-chaired the committee that oversaw the merger of substance abuse and mental health services into a new Department of Behavioral Health in order to create a true co-occurring, recovery-oriented system of care.

Before assuming the position as Interim Director of DOH, Dr. Levin served as the Senior Deputy Director of the Addiction Prevention and Recovery Administration in DOH from March, 2012 to July, 2012. During his tenure at APRA, Dr. Levin promoted substance abuse prevention efforts in all eight wards of the city through the work of the Prevention and Access to Recovery teams, assessed and referred an increasing number of individuals into treatment services, as well as connected more clients to recovery support services.

Prior to joining DOH, Dr. Levin served as Vice President of the American Medical Association for Science, Medicine and Public Health, oversaw programs consistent with the needs of evolving health delivery systems, from prevention to science policy to health care disparities. He also led efforts to improve the interface between clinical medicine and public health.

Dr. Levin’s professional career also includes: serving as a special expert appointee in the Substance Abuse and Mental Health Services Administration, a division of the United States Department of Health and Human Services, where he led the initiative to integrate primary care, substance abuse, mental health and HIV/AIDS. When serving as President for Access Consulting International, Inc., Dr. Levin

worked with federal, state, local governments and private companies to provide health and human service policy, program, and research and evaluation services. He also served as President and CEO of Medical Education for South African Blacks, which was as an anti-apartheid education trust that provided scholarships to South African black students in the health care arena. In this capacity, Dr. Levin helped award more than 11,000 scholarships to students studying to become doctors, nurses, substance abuse counselors and other health care professionals.

In 1982, Dr. Levin received his MBBch (MD), Medicine from the University Witwatersrand in Johannesburg, South Africa, and completed his residency in Psychiatry at the University of California Davis Medical Center. In 1994, he received his Master’s in Public Administration (MPA) from Harvard University Kennedy School of Government.

Conference Secretariat: Scatterlings Conference & Events 


Telephone:  +27  11 463 5085

Fax:   +27 11 463 3265





International Delegate Coordinator

Carina du Plessis


Abstract/ Poster Coordination

Simone Solomons


South African Delegate Coordinator

Stephanie de Boer


visalg mcsm vbyv sm mc securecode sm paygate logo transparent HD small

Copyright. WPA 2016. All Rights Reserved. Powered By: Scatterlings Conferences & Events | Terms & Conditions